Weight & Metabolism Peptides: A Research Breakdown
Fat metabolism and appetite regulation involve overlapping hormone pathways. Here's what current peptide research says about each one.
Peptides for Weight & Metabolism
Click on the card to read the full research guide.
AOD-9604
A modified fragment of human growth hormone studied specifically for its proposed effect on fat metabolism without the broader GH response.
Read the research guide →Tesamorelin
A GHRH analog researched most extensively for its effect on visceral fat, with a notable body of published clinical literature.
Read the research guide →Semaglutide
A GLP-1 receptor agonist studied extensively for appetite regulation and glucose metabolism, among the most clinically researched compounds in this category.
Read the research guide →Tirzepatide
A dual GIP/GLP-1 receptor agonist researched for its combined effect on appetite signaling and insulin sensitivity.
Read the research guide →MOTS-c
Studied for its role in metabolic regulation and insulin sensitivity at the mitochondrial level.
Read the research guide →CJC-1295
A GHRH analog researched for extending GH pulse amplitude, a pathway connected to fat and lean-mass metabolism.
Read the research guide →Weight & Metabolism Research Community Discussions
General patterns seen across peptide research forums and discussion boards, not verified outcomes or individual endorsements.
- Semaglutide and Tirzepatide dominate most metabolic-peptide discussion by volume, reflecting how much clinical research now exists compared to older compounds.
- Tesamorelin threads frequently reference its original clinical trials in visceral fat research, giving it more citation-backed discussion than most peptides on this page.
- AOD-9604 discussion tends to be more speculative, with contributors noting the comparatively thin research base relative to its popularity.
- MOTS-c comes up often in threads connecting metabolic and longevity research, rather than as a standalone weight-focused compound.
- CJC-1295 discussion in this category usually centers on body-composition research rather than direct weight-loss claims.
- A consistent theme: contributors distinguishing between compounds with substantial published clinical data (Semaglutide, Tirzepatide, Tesamorelin) and those still mostly in early-stage research (AOD-9604, MOTS-c).
Safety & Legality
- AOD-9604, Tesamorelin, Semaglutide, Tirzepatide, MOTS-c, and CJC-1295 are sold and discussed here strictly for laboratory research use, not for human consumption, except where a specific formulation carries separate regulatory approval.
- Semaglutide and Tirzepatide have approved pharmaceutical formulations for specific medical uses; research-grade versions sold for laboratory use are not equivalent to and should not be confused with those approved products.
- None of the information on this page constitutes medical advice regarding weight management.
- Research peptide legality varies by country and state. Confirm local regulations before purchasing or importing any compound.
- Always source from suppliers who provide a Certificate of Analysis (COA) for purity and identity testing.
Related Guides
Get New Compound Research, Before It’s Old News
One email when a study, mechanism update, or new compound guide goes live. No spam, unsubscribe anytime.
Research summaries and updates only. We never share your email.